{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-001789","form_type":"8-K","ticker":"LTRN","cik":"0001763950","company_name":"Lantern Pharma Inc.","filed_at":"2023-01-18T23:59:59+00:00","discovered_at":"2026-05-14T18:03:46.457540+00:00","generated_at":"2026-06-20T14:08:09.355642+00:00","sec_items":["5.02"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"Lantern Pharma raises CSO Kishor Bhatia's base salary to $235,000 effective Jan 2023","bullets":["Board approved amendment to employment agreement increasing annual base salary to $235,000.","Increase takes effect with the first pay period in January 2023.","Dr. Bhatia continues as Chief Scientific Officer of Lantern Pharma."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-001789","json":"https://secwatch.observer/filing/0001493152-23-001789.json","markdown":"https://secwatch.observer/filing/0001493152-23-001789.md","text":"https://secwatch.observer/filing/0001493152-23-001789.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1763950/000149315223001789/0001493152-23-001789-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1763950/000149315223001789/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-20T14:08:09.355642+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}